CONMED
CNMD
273 hedge funds and large institutions have $1.63B invested in CONMED in 2025 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 95 increasing their positions, 100 reducing their positions, and 47 closing their positions.
1,490% more call options, than puts
Call options by funds: $3.44M | Put options by funds: $216K
4% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 47
5% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 100
1.4% less ownership
Funds ownership: 113.05% → 111.64% (-1.4%)
1% less funds holding
Funds holding: 277 → 273 (-4)
11% less capital invested
Capital invested by funds: $1.82B → $1.63B (-$198M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$51.8M |
| 2 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$21.8M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
+$11.5M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$11.1M |
| 5 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
+$10.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$50.3M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$43.5M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$33.4M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$10.8M |
| 5 |
BlackRock
New York
|
-$9.72M |
CNMD Hedge Fund Activity: Q3 2025 in Review
273 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q3 2025, worth a combined $1.63B — down 11% from $1.82B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of CNMD and 45 opened new positions — a net loss of 2 holders — while 100 trimmed existing stakes and 95 added.
The largest buyer was Wasatch Advisors, opening a new position worth an estimated $51.8M. The largest seller was Macquarie Group, exiting entirely with an estimated $50.3M sold.
- 273 institutional investors held CONMED (CNMD) as of Q3 2025, down from 277 in Q2 2025.
- Funds reported $1.63B of CONMED stock for Q3 2025, down 11% quarter-over-quarter.
- 45 funds opened new CONMED positions in Q3 2025 and 47 closed out, a net change of -2 holders.
- The largest CONMED buyer in Q3 2025 was Wasatch Advisors, an estimated $51.8M added.
- The largest CONMED seller in Q3 2025 was Macquarie Group, an estimated $50.3M sold.
Based on aggregated 13F filings for Q3 2025.